XENiOS
Heilbronn, Baden-Wurttemberg, Germany · Founded 2013
About XENiOS
XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Funding stage: M&A
- Last round: Seed (Sep 2015)
- Website: xenios-ag.com
- Phone: +4971312706100
Industries & Categories
Health Care, Medical, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/xenios-2462246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.